These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Treatment of obsessive-compulsive disorders: recommendations of the revised S3 guidelines on obsessive-compulsive disorders]. Voderholzer U; Favreau M; Rubart A; Staniloiu A; Wahl-Kordon A; Zurowski B; Kathmann N Nervenarzt; 2022 Jul; 93(7):678-687. PubMed ID: 35763051 [TBL] [Abstract][Full Text] [Related]
6. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. Franklin ME; Sapyta J; Freeman JB; Khanna M; Compton S; Almirall D; Moore P; Choate-Summers M; Garcia A; Edson AL; Foa EB; March JS JAMA; 2011 Sep; 306(11):1224-32. PubMed ID: 21934055 [TBL] [Abstract][Full Text] [Related]
7. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. Pediatric OCD Treatment Study (POTS) Team JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582 [TBL] [Abstract][Full Text] [Related]